Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Low doses of lysergic acid diethylamide (LSD) increase reward-related brain activity
James E. Glazer, Conor H. Murray, Robin Nusslock, et al.
Neuropsychopharmacology (2022) Vol. 48, Iss. 2, pp. 418-426
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Identification of the subventricular tegmental nucleus as brainstem reward center
Krisztián Zichó, Boldizsár Zsolt Balog, Réka Z. Sebestény, et al.
Science (2025) Vol. 387, Iss. 6732
Closed Access | Times Cited: 2
The Therapeutic Potential of Psychedelics in Treating Substance Use Disorders: A Review of Clinical Trials
Lavinia Hogea, Dana Cătălina Tabugan, Iuliana Costea, et al.
Medicina (2025) Vol. 61, Iss. 2, pp. 278-278
Open Access | Times Cited: 2
Psychedelic therapy in the treatment of addiction: the past, present and future
Rayyan Zafar, Maxim Siegel, Rebecca Harding, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 37
Neural complexity is increased after low doses of LSD, but not moderate to high doses of oral THC or methamphetamine
Conor H. Murray, Joel Frohlich, Connor J. Haggarty, et al.
Neuropsychopharmacology (2024)
Closed Access | Times Cited: 12
Microdosing Psychedelics: Current Evidence From Controlled Studies
Robin J. Murphy, Suresh Muthukumaraswamy, Harriet de Wit
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2024) Vol. 9, Iss. 5, pp. 500-511
Open Access | Times Cited: 10
Modulation of long-term potentiation following microdoses of LSD captured by thalamo-cortical modelling in a randomised, controlled trial
Robin J. Murphy, Kate Godfrey, Alexander D. Shaw, et al.
BMC Neuroscience (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 9
Potential Differences in Psychedelic Actions Based on Biological Sex
Sheida Shadani, Kyna‐Anne Conn, Zane B. Andrews, et al.
Endocrinology (2024) Vol. 165, Iss. 8
Open Access | Times Cited: 9
Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms
Abigail E. Calder, Seline Mock, Nicole Friedli, et al.
European Neuropsychopharmacology (2023) Vol. 75, pp. 1-14
Open Access | Times Cited: 19
Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research
Vince Polito, Paul Liknaitzky
Journal of Psychopharmacology (2024) Vol. 38, Iss. 8, pp. 701-711
Open Access | Times Cited: 4
Therapeutic Efficacy of Reward Circuit‐Targeted Transcranial Magnetic Stimulation (TMS) on Suicidal Ideation in Depressed Patients: A Sham‐Controlled Trial of Two TMS Protocols
Xinyu Huang, Chunhua Xi, Ya Fang, et al.
Depression and Anxiety (2025) Vol. 2025, Iss. 1
Open Access
Low (micro)doses of 2,5-dimethoxy-4-propylamphetamine (DOPR) increase effortful motivation in low-performing mice
Michael Noback, Johnny A. Kenton, Adam K. Klein, et al.
Neuropharmacology (2025), pp. 110334-110334
Closed Access
Psychedelic Drugs in Mental Disorders: Current Clinical Scope and Deep Learning‐Based Advanced Perspectives
Sung‐Hyun Kim, Sumin Yang, Jeehye Jung, et al.
Advanced Science (2025)
Open Access
Potential therapeutic effects of psychedelics in small doses: Is there a role for microdosing in psychiatry?
Iva Totomanova, Eline Haijen, Petra P.M. Hurks, et al.
International review of neurobiology (2025)
Closed Access
The compulsive eating paradigm: can psychedelics help in treating obesity?
Dhanush Ammineni, Rebecca J. Park
Journal of Eating Disorders (2025) Vol. 13, Iss. 1
Open Access
Disentangling the acute subjective effects of classic psychedelics from their enduring therapeutic properties
Mazen A. Atiq, Matthew Baker, Jennifer L. Vande Voort, et al.
Psychopharmacology (2024)
Open Access | Times Cited: 4
Greater subjective effects of a low dose of LSD in participants with depressed mood
Hanna Molla, Royce Lee, Ilaria Tare, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 5, pp. 774-781
Closed Access | Times Cited: 10
Psychedelic Microdosing among Young Adults from Southern California
Alyssa F. Harlow, Peter S. Hendricks, Adam M. Leventhal, et al.
Journal of Psychoactive Drugs (2024), pp. 1-12
Closed Access | Times Cited: 3
Dose-dependent LSD effects on cortical/thalamic and cerebellar activity: brain oxygen level-dependent fMRI study in awake rats
Ashley Ghaw, Alisha Chunduri, Arnold Chang, et al.
Brain Communications (2024) Vol. 6, Iss. 3
Open Access | Times Cited: 3
Significant Psychedelic Experiences Evaluated for Mystical Characteristics Associated with Cannabis Use Reduction and Psychological Flexibility Improvement: A Naturalistic Cross-Sectional Retrospective Survey
Bruno Roméo, E. Kervadec, Baptiste Fauvel, et al.
Journal of Psychoactive Drugs (2024), pp. 1-12
Closed Access | Times Cited: 3
Synthesis and Structure–Activity Relationships of 2,5-Dimethoxy-4-Substituted Phenethylamines and the Discovery of CYB210010: A Potent, Orally Bioavailable and Long-Acting Serotonin 5-HT2 Receptor Agonist
Geoffrey B. Varty, Clinton E. Canal, Tina A. Mueller, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6144-6188
Closed Access | Times Cited: 2
LSD increases sleep duration the night after microdosing
Nathan Allen, Aron Jeremiah, Robin J. Murphy, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Aberrant social reward dynamics in individuals with melancholic major depressive disorder: An ERP study
Qiaoyang Zhang, Ciqing Bao, Rui Yan, et al.
Journal of Affective Disorders (2024) Vol. 361, pp. 751-759
Closed Access | Times Cited: 2
The Influence of Stakeholder Interests on Safety Outcome Reporting in Psychedelic Research and Implications for Science Communication
Elena Koning, Marco Solmi, Elisa Brietzke
Trends in Psychiatry and Psychotherapy (2024)
Open Access | Times Cited: 2
Better Biomarkers, Faster Drugs, Stronger Models: Progress Towards Precision Psychiatry.
Joshua S. Siegel, Craig Pearson, Eric J. Lenze
PubMed (2023) Vol. 120, Iss. 4, pp. 292-298
Closed Access | Times Cited: 5
Inter-individual variability in neural response to low doses of LSD
Nadia R. P. W. Hutten, Conny W.E.M. Quaedflieg, Natasha L. Mason, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top